Vice President, Pharmacovigilance & Drug Safety jobs in United States
cer-icon
Apply on Employer Site
company-logo

Immunome, Inc. · 4 days ago

Vice President, Pharmacovigilance & Drug Safety

Immunome, Inc. is a clinical-stage targeted oncology company focused on developing innovative cancer therapies. The Vice President, Pharmacovigilance & Drug Safety will lead the global safety strategy, ensuring compliance and overseeing drug safety operations across the company's pipeline.

BiopharmaBiotechnologyMedicalPharmaceutical

Responsibilities

Develop and implement the pharmacovigilance strategy in alignment with regulatory requirements and company goals
Build and develop a team of drug safety professionals to evaluate and oversee safety reporting and management
Oversee the collection, analysis, and reporting of safety data from ongoing clinical trials
Oversee the development of drug safety databases and reporting procedures to ensure regulatory compliance
Lead the preparation and submission of safety reports, including Periodic Safety Update Reports and other regulatory filings
Lead the safety analysis for regulatory submissions including NDAs, BLAs and MAAs
Ensure compliance with global regulatory requirements and guidelines, including those from the FDA, EMA, and ICH
Collaborate with Clinical Development, Regulatory Affairs, and Quality Assurance teams to ensure integrated approaches to drug safety. Provide expert safety guidance during development of protocols and other site-facing documents
Provide expert guidance on risk management and mitigation strategies throughout the product lifecycle
Conduct regular training for staff on pharmacovigilance practices and regulatory updates
Analyze safety data trends and provide actionable insights to senior management and stakeholders
Represent the pharmacovigilance function in meetings with regulatory authorities and during audits
Provide medical expertise to clinical teams in evaluation of safety events

Qualification

PharmacovigilanceDrug SafetySignal DetectionRisk ManagementRegulatory ComplianceData AnalysisLeadershipCommunication SkillsInterpersonal SkillsProblem-Solving Skills

Required

M.D., D.O., or equivalent advanced degree in life sciences or pharmacology required; additional training in oncology or drug safety highly preferred
A minimum of 10 years of pharmacovigilance and drug safety experience in biotech and/or pharmaceutical settings, including a minimum of 5 years in a senior leadership role with global responsibilities
Strong knowledge of global pharmacovigilance regulations and industry standards. Deep expertise in global pharmacovigilance regulations (FDA, EMA, ICH, MHRA, PMDA) and evolving industry best practices
Proven track record of managing safety data and conducting signal detection and risk assessment. Proven ability to lead signal detection, aggregate safety data review, benefit–risk assessment, and implementation of proactive risk management strategies
Demonstrated ability to build a highly functioning team. Demonstrated success in building, mentoring, and scaling high‑performing global pharmacovigilance and drug safety teams
Excellent communication, leadership, and interpersonal skills
Ability to work collaboratively in a fast-paced, dynamic environment
Strong analytical and problem-solving skills

Company

Immunome, Inc.

twittertwittertwitter
company-logo
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.

Funding

Current Stage
Public Company
Total Funding
$998.85M
Key Investors
JPEO-CBRNDU.S. Department of DefenseRobin Hood Ventures
2025-12-16Post Ipo Equity· $400M
2025-01-29Post Ipo Equity· $150M
2024-02-13Post Ipo Equity· $230M

Leadership Team

leader-logo
Clay Siegall
President and CEO
linkedin
leader-logo
Purnanand D. Sarma
President & CEO
linkedin

Recent News

BioWorld Financial Watch
Company data provided by crunchbase